Phenotypic PMN profiling using established maturity markers revealed the transition from CD101hi/CXCR2+ mature PMNs in spleen, peripheral blood, and tumor-adjacent tissues to previously reported protumorigenic CD101lo/CXCR2neg TANs (Supplemental Figure 1, H and I). Here, CXCR2 is linked to neoplasm.